These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3073074

  • 21. Glomerular dysfunction in diabetic nephropathy.
    Zucchelli P, Zuccalà A, Sturani A.
    Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
    [Abstract] [Full Text] [Related]

  • 22. Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union.
    Gerth WC, Remuzzi G, Viberti G, Hannedouche T, Martinez-Castelao A, Shahinfar S, Carides GW, Brenner B.
    Kidney Int Suppl; 2002 Dec; (82):S68-72. PubMed ID: 12410859
    [Abstract] [Full Text] [Related]

  • 23. Diabetic nephropathy: from micro- to macroalbuminuria.
    Deferrari G, Repetto M, Calvi C, Ciabattoni M, Rossi C, Robaudo C.
    Nephrol Dial Transplant; 1998 Dec; 13 Suppl 8():11-5. PubMed ID: 9870419
    [Abstract] [Full Text] [Related]

  • 24. Epidemiologic analysis of diabetic patients on chronic dialysis.
    Sunagawa H, Iseki K, Nishime K, Uehara H, Toma S, Kinjo K, Fukiyama K.
    Nephron; 1996 Dec; 74(2):361-6. PubMed ID: 8893156
    [Abstract] [Full Text] [Related]

  • 25. Premature cell ageing and evolution of diabetic nephropathy.
    Morocutti A, Earle KA, Rodemann HP, Viberti GC.
    Diabetologia; 1997 Feb; 40(2):244-6. PubMed ID: 9049488
    [Abstract] [Full Text] [Related]

  • 26. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT, Hostetter TH.
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The health care costs of diabetic nephropathy in the United States and the United Kingdom.
    Gordois A, Scuffham P, Shearer A, Oglesby A.
    J Diabetes Complications; 2004 Mar; 18(1):18-26. PubMed ID: 15019595
    [Abstract] [Full Text] [Related]

  • 29. Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy.
    Bretzel RG.
    Am J Hypertens; 1997 Sep; 10(9 Pt 2):208S-217S. PubMed ID: 9324124
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
    Zander E, Seidlein I, Herfurth S, Heinke P, Chlup R, Badendick K, Strese J, Zander G, Schulz B.
    Exp Clin Endocrinol; 1992 Sep; 99(2):102-7. PubMed ID: 1639116
    [Abstract] [Full Text] [Related]

  • 32. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M, Jakić M, Zibar L, Mihaljević D, Stipanić S, Teskera T.
    Lijec Vjesn; 2009 Sep; 131(7-8):218-25. PubMed ID: 19769285
    [Abstract] [Full Text] [Related]

  • 33. Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.
    Garattini L, Brunetti M, Salvioni F, Barosi M.
    Pharmacoeconomics; 1997 Jul; 12(1):67-75. PubMed ID: 10169388
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Recent advances in understanding mechanisms and natural history of diabetic renal disease.
    Viberti G.
    Diabetes Care; 1988 Jul; 11 Suppl 1():3-9. PubMed ID: 3069389
    [Abstract] [Full Text] [Related]

  • 36. The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy.
    Carides GW, Shahinfar S, Dasbach EJ, Keane WF, Gerth WC, Alexander CM, Herman WH, Brenner BM, RENAAL Investigators.
    Pharmacoeconomics; 2006 Jul; 24(6):549-58. PubMed ID: 16761903
    [Abstract] [Full Text] [Related]

  • 37. Renal protection and antihypertensive drugs: current status.
    Salvetti A, Mattei P, Sudano I.
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Diabetic nephropathy: natural course, survivorship and therapy.
    McCrary RF, Pitts TO, Puschett JB.
    Am J Nephrol; 1981 May; 1(3-4):206-18. PubMed ID: 6758579
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.